DE69909068T2 - Substituierte bisindolylmaleimide zur inhibierung der zellproliferation - Google Patents

Substituierte bisindolylmaleimide zur inhibierung der zellproliferation Download PDF

Info

Publication number
DE69909068T2
DE69909068T2 DE69909068T DE69909068T DE69909068T2 DE 69909068 T2 DE69909068 T2 DE 69909068T2 DE 69909068 T DE69909068 T DE 69909068T DE 69909068 T DE69909068 T DE 69909068T DE 69909068 T2 DE69909068 T2 DE 69909068T2
Authority
DE
Germany
Prior art keywords
indol
methyl
nitro
mmol
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69909068T
Other languages
German (de)
English (en)
Other versions
DE69909068D1 (de
Inventor
Hooda Urvashi DHINGRA
Mary Donna HURYN
June Ke
Federico Giuseppe WEBER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69909068D1 publication Critical patent/DE69909068D1/de
Application granted granted Critical
Publication of DE69909068T2 publication Critical patent/DE69909068T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69909068T 1998-03-17 1999-03-10 Substituierte bisindolylmaleimide zur inhibierung der zellproliferation Expired - Lifetime DE69909068T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7833198P 1998-03-17 1998-03-17
US78331P 1998-03-17
PCT/EP1999/001534 WO1999047518A1 (en) 1998-03-17 1999-03-10 Substituted bisindolymaleimides for the inhibition of cell proliferation

Publications (2)

Publication Number Publication Date
DE69909068D1 DE69909068D1 (de) 2003-07-31
DE69909068T2 true DE69909068T2 (de) 2004-05-06

Family

ID=22143350

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69909068T Expired - Lifetime DE69909068T2 (de) 1998-03-17 1999-03-10 Substituierte bisindolylmaleimide zur inhibierung der zellproliferation

Country Status (33)

Country Link
US (1) US6048887A (https=)
EP (1) EP1064279B1 (https=)
JP (2) JP5026633B2 (https=)
KR (1) KR100659411B1 (https=)
CN (1) CN1127500C (https=)
AR (1) AR018162A1 (https=)
AT (1) ATE243693T1 (https=)
AU (1) AU755673B2 (https=)
BR (1) BR9908882A (https=)
CA (1) CA2322689C (https=)
CO (1) CO5070675A1 (https=)
CZ (1) CZ299068B6 (https=)
DE (1) DE69909068T2 (https=)
DK (1) DK1064279T3 (https=)
ES (1) ES2203111T3 (https=)
HR (1) HRP20000585B1 (https=)
HU (1) HU228831B1 (https=)
ID (1) ID26353A (https=)
IL (1) IL138247A (https=)
MA (1) MA26613A1 (https=)
MY (1) MY121046A (https=)
NO (1) NO320306B1 (https=)
NZ (1) NZ506476A (https=)
PE (1) PE20000340A1 (https=)
PL (1) PL195323B1 (https=)
PT (1) PT1064279E (https=)
RS (1) RS49965B (https=)
RU (1) RU2208612C2 (https=)
SA (1) SA99191295B1 (https=)
TR (1) TR200002580T2 (https=)
TW (1) TW539676B (https=)
WO (1) WO1999047518A1 (https=)
ZA (1) ZA992072B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2203111T3 (es) * 1998-03-17 2004-04-01 F. Hoffmann-La Roche Ag Maleimidas bisindol sustituidas para la inhibicion de proloferacion celular.
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
TR200200987T2 (tr) * 1999-10-12 2002-09-23 F.Hoffmann-La Roche Ag Kanser tedavisine yönelik,ornatılmış pirroller
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
US7129250B2 (en) * 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
US6482847B2 (en) 2000-10-03 2002-11-19 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6469179B1 (en) 2000-10-03 2002-10-22 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6548531B2 (en) 2001-02-09 2003-04-15 Hoffmann-La Roche Inc. Method for cancer therapy
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
WO2008117935A1 (en) * 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same
CN102924437B (zh) * 2012-11-19 2014-07-02 东华大学 3-哌嗪基-4-吲哚马来酰亚胺化合物及其制备和应用
WO2019000224A1 (zh) * 2017-06-27 2019-01-03 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ280738B6 (cs) * 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
ES2236702T3 (es) * 1993-12-23 2005-07-16 Eli Lilly And Company Inhibidores de la proteina quinasa c.
PE91598A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
ES2203111T3 (es) * 1998-03-17 2004-04-01 F. Hoffmann-La Roche Ag Maleimidas bisindol sustituidas para la inhibicion de proloferacion celular.

Also Published As

Publication number Publication date
AR018162A1 (es) 2001-10-31
CA2322689C (en) 2008-11-25
YU55200A (sh) 2002-11-15
HUP0101258A3 (en) 2002-08-28
ATE243693T1 (de) 2003-07-15
WO1999047518A1 (en) 1999-09-23
DK1064279T3 (da) 2003-10-06
CN1293671A (zh) 2001-05-02
CZ20003384A3 (cs) 2000-12-13
EP1064279B1 (en) 2003-06-25
IL138247A (en) 2005-08-31
NO20004579L (no) 2000-09-14
KR100659411B1 (ko) 2006-12-18
PL342964A1 (en) 2001-07-16
NZ506476A (en) 2003-12-19
NO20004579D0 (no) 2000-09-14
HUP0101258A2 (hu) 2001-10-28
EP1064279A1 (en) 2001-01-03
ES2203111T3 (es) 2004-04-01
CZ299068B6 (cs) 2008-04-16
HK1036452A1 (en) 2002-01-04
CN1127500C (zh) 2003-11-12
HRP20000585B1 (en) 2009-02-28
JP2002506864A (ja) 2002-03-05
MA26613A1 (fr) 2004-12-20
SA99191295B1 (ar) 2006-04-26
RU2208612C2 (ru) 2003-07-20
AU3409999A (en) 1999-10-11
JP2010222366A (ja) 2010-10-07
HRP20000585A2 (en) 2001-08-31
IL138247A0 (en) 2001-10-31
ZA992072B (en) 1999-09-22
RS49965B (sr) 2008-09-29
AU755673B2 (en) 2002-12-19
CO5070675A1 (es) 2001-08-28
TR200002580T2 (tr) 2000-11-21
DE69909068D1 (de) 2003-07-31
US6048887A (en) 2000-04-11
PT1064279E (pt) 2003-10-31
BR9908882A (pt) 2000-11-21
CA2322689A1 (en) 1999-09-23
ID26353A (id) 2000-12-14
KR20010041995A (ko) 2001-05-25
JP5026633B2 (ja) 2012-09-12
TW539676B (en) 2003-07-01
MY121046A (en) 2005-12-30
HU228831B1 (en) 2013-05-28
PL195323B1 (pl) 2007-09-28
PE20000340A1 (es) 2000-05-13
NO320306B1 (no) 2005-11-21

Similar Documents

Publication Publication Date Title
DE69909068T2 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
DE60316013T2 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
EP0207331B1 (de) Neue feste Formen von 2-Äthoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoesäure, diese Formen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE60319255T2 (de) Pyrimidoverbindungen mit antiproliferativer wirkung
DE10148618B4 (de) Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
EP1082308B1 (de) Heterocyclisch substituierte amide als calpainhemmer
DE69009315T2 (de) Cinnamamidderivate.
DE69722003T2 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
WO1996002520A1 (de) Triazolverbindungen und deren verwendung als dopamin-d3-liganden
DE69533284T2 (de) Neue cyclische und acyclische amide zur erhöhung der neurotransmitter ausschüttung
DE69601527T2 (de) Pyrrolylbenzimidazol-Derivate
DE60012288T2 (de) Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung
DE68917569T2 (de) 4-Aminophenol-Derivate und Verfahren zu ihrer Herstellung.
EP0002672B1 (de) Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0262395A2 (de) Sulfonamido-äthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0283857A1 (de) Benzylidenamino-, benzylamino- und benzoylamino-imidazolderivate
DE60107852T2 (de) Thienopyrrolidinone
DE60132782T2 (de) Prodrugs zu nmda-rezeptorliganden
DE19539091A1 (de) 5-gliedrige Heterocyclen, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zur ihrer Herstellung
EP1585728B1 (de) Iminosäurederivate als inhibitoren von matrix-metalloproteinasen
DE60023182T2 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
DE10148617A1 (de) Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
EP0129509B1 (de) Triazol(2,3-c)(1,3)benzodiazepine, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
EP0001585A1 (de) Piperazino-pyrrolobenzodiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Präparate enthaltend diese Verbindungen
EP0041627B1 (de) 3H-2-Benzazepine, Zwischenprodukte und Verfahren zu ihrer Herstellung, sowie diese enthaltende Präparate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition